![Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment | Scientific Reports Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-99184-1/MediaObjects/41598_2021_99184_Fig2_HTML.png)
Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment | Scientific Reports
![Frontiers | CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine | Pharmacology Frontiers | CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine | Pharmacology](https://www.frontiersin.org/files/Articles/500191/fphar-10-01662-HTML/image_m/fphar-10-01662-g004.jpg)
Frontiers | CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine | Pharmacology
![Cureus | A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy Cureus | A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy](https://assets.cureus.com/uploads/figure/file/227481/lightbox_715b2360cba611eba12eb94210d15e3b-Picture1-2-.png)
Cureus | A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
![IJMS | Free Full-Text | Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches | HTML IJMS | Free Full-Text | Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches | HTML](https://www.mdpi.com/ijms/ijms-22-01952/article_deploy/html/images/ijms-22-01952-g001.png)
IJMS | Free Full-Text | Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches | HTML
![JCI Insight - Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination JCI Insight - Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination](https://df6sxcketz7bb.cloudfront.net/manuscripts/139000/139983/medium/jci.insight.139983.f5.jpg)
JCI Insight - Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
![Frontiers | Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies | Pharmacology Frontiers | Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies | Pharmacology](https://www.frontiersin.org/files/Articles/557827/fphar-11-01096-HTML/image_m/fphar-11-01096-g001.jpg)
Frontiers | Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies | Pharmacology
![Allele-Specific Prevention of Nonsense-Mediated Decay in Cystic Fibrosis Using Homology-Independent Genome Editing: Molecular Therapy - Methods & Clinical Development Allele-Specific Prevention of Nonsense-Mediated Decay in Cystic Fibrosis Using Homology-Independent Genome Editing: Molecular Therapy - Methods & Clinical Development](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/060ef02c-199d-43f2-ad21-b445b871f12d/fx1_lrg.jpg)